Battle Against Killer Viruses: HIV, HBV and SARS-CoV-2

Hiroaki Mitsuya, MD/PhD

Department of Refractory Viral Infections, National Center for Global Health & Medicine, Tokyo, Japan

National Kumamoto University Hospital, Kumamoto, Japan

Experimental Retrovirology Section, HIV & AIDS Malignancy Branch, National Cancer Institute, NIH